101 related articles for article (PubMed ID: 7545047)
1. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
Kertes PJ; Britton WA; Leonard BC
Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
[No Abstract] [Full Text] [Related]
4. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
5. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
[TBL] [Abstract][Full Text] [Related]
6. The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study.
Chan CK; Kempin SJ; Noble SK; Palmer GA
Ophthalmology; 1994 Feb; 101(2):289-300. PubMed ID: 7509472
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
[TBL] [Abstract][Full Text] [Related]
10. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.
Reichel E; Berrocal AM; Ip M; Kroll AJ; Desai V; Duker JS; Puliafito CA
Ophthalmology; 1999 Oct; 106(10):1908-14. PubMed ID: 10519584
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
Thomas MA; Ibanez HE
Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
[TBL] [Abstract][Full Text] [Related]
12. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.
Engler C; Sander B; Villumsen J; Lund-Andersen H
Br J Ophthalmol; 1994 Oct; 78(10):749-53. PubMed ID: 7528534
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
[TBL] [Abstract][Full Text] [Related]
14. Low dose radiation for subfoveal choroidal neovascularization in age-related macular degeneration. A pilot study: radiotherapy for age-related macular degeneration.
Valmaggia C; Bischoff P; Ries G; Seelentag W; Niederberger H; Speiser P
Doc Ophthalmol; 1997; 93(4):317-26. PubMed ID: 9665289
[TBL] [Abstract][Full Text] [Related]
15. Visual results after submacular surgery for neovascularization in age-related macular degeneration.
Roth DB; Downie AA; Charles ST
Ophthalmic Surg Lasers; 1997 Nov; 28(11):920-5. PubMed ID: 9387179
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of age-associated macular degeneration with interferon-alfa-2a].
Thölen A; Kain H; Messmer E
Ophthalmologe; 1993 Jun; 90(3):279-82. PubMed ID: 8334332
[TBL] [Abstract][Full Text] [Related]
17. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
[TBL] [Abstract][Full Text] [Related]
18. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
[TBL] [Abstract][Full Text] [Related]
19. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration.
Jaakkola A; Heikkonen J; Tommila P; Laatikainen L; Immonen I
Graefes Arch Clin Exp Ophthalmol; 1998 Jan; 236(1):24-30. PubMed ID: 9457513
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation.
Bergink GJ; Hoyng CB; van der Maazen RW; Vingerling JR; van Daal WA; Deutman AF
Graefes Arch Clin Exp Ophthalmol; 1998 May; 236(5):321-5. PubMed ID: 9602314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
